Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 71.50 INR
Change Today +1.45 / 2.07%
Volume 30.4K
As of 12:40 AM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

bal pharma ltd (BLP) Snapshot

Open
71.10
Previous Close
70.05
Day High
73.70
Day Low
70.50
52 Week High
11/5/14 - 104.00
52 Week Low
03/27/15 - 49.50
Market Cap
920.4M
Average Volume 10 Days
45.9K
EPS TTM
2.83
Shares Outstanding
12.9M
EX-Date
--
P/E TM
25.3x
Dividend
1.00
Dividend Yield
1.39%
Current Stock Chart for BAL PHARMA LTD (BLP)

Related News

No related news articles were found.

bal pharma ltd (BLP) Related Businessweek News

No Related Businessweek News Found

bal pharma ltd (BLP) Details

Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (API) in India. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It also provides a range of APIs for therapeutic areas, such as acne treatment, diuretic, anti-histamine, anti-inflammatory, anti-diabetic, sedative/hypnotic, anti-allergy, neuropathic pain, urinary incontinence, anti-convulsant, and insomnia, as well as offers various finished formulations. The company also provides ayurvedic products comprising ANARSHA for regularize bowl movement; ASHWAMED for sexual and general debility; AYURFINE and AYURFINE FORTE, an anti arthritics for osteoarthritis, rheumatoid arthritis, and spondylitis; AYURSULIN for managing diabetes; IMMUWIN, an immune building supplement; and LIPIVED for reducing cholesterol. Its ayurvedic products also consist of MENOLEAP capsules and syrup for menstrual disorders; PROLIFE, which provides life to ailing liver; BALPRO SYRUP for stable and synchronized liver functions; PROSTOWIN for benign prostatic hyperplasia; STONEX for expulsion of kidney stones; SUJIRNA for digestion; SUSWAS, an antallergic/antiasthamatic product; and BALVAC, a mild laxative. The company also exports its products to Europe, Latin America, Africa, the Middle East, and Asian markets. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.

Founded in 1987

bal pharma ltd (BLP) Top Compensated Officers

Managing Director, Executive Director, Member...
Total Annual Compensation: 6.0M
Whole-Time Director, Chairman of Banking Tran...
Total Annual Compensation: 2.7M
Compensation as of Fiscal Year 2014.

bal pharma ltd (BLP) Key Developments

Bal Pharma Limited Announces Resignation of Murali. V as AVP Finance and Company Secretary

Bal Pharma Limited has announced that Mr. Murali. V, AVP Finance and Company Secretary of the company has resigned from the services of the company, citing personal reasons. The Board has approved the resignation of Mr. Murali. V and has expressed its appreciation for the services rendered by him during his tenure.

Bal Pharma Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2015 and Consolidated Earnings Results for the Full Year Ended March 31, 2015

Bal Pharma Limited reported audited standalone earnings results for the fourth quarter and full year ended March 31, 2015 and consolidated earnings results for the full year ended March 31, 2015. For the quarter, the company reported net sales of INR 499.390 million compared to INR 466.207 million reported in the same period last year. Profit from operations before other income, interest and exceptional items was INR 13.913 million against INR 33.905 million reported last year. Profit from ordinary activities before tax was INR 6.403 million against INR 19.440 million reported last year. Net profit was INR 5.567 million or INR 0.43 per diluted share against INR 13.576 million or INR 1.21 per diluted share reported last year. For the year, on standalone basis, the company reported net sales of INR 1,824.570 million compared to INR 1,734.140 million reported in the same period last year. Profit from operations before other income, interest and exceptional items was INR 105.226 million against INR 131.371 million reported last year. Profit from ordinary activities before tax was INR 52.012 million against INR 66.260 million reported last year. Net profit was INR 40.228 million or INR 3.11 per diluted share against INR 50.723 million or INR 4.60 per diluted share reported last year. For the year, on consolidated basis, the company reported net sales of INR 1,824.843 million compared to INR 1,734.140 million reported in the same period last year. Profit from operations before other income, interest and exceptional items was INR 100.828 million against INR 131.371 million reported last year. Profit from ordinary activities before tax was INR 47.405 million against INR 66.260 million reported last year. Net profit was INR 35.531 million or INR 2.80 per diluted share against INR 50.723 million or INR 4.60 per diluted share reported last year.

Bal Pharma Limited Recommends Dividend for the Financial Year Ended March 31, 2015

Bal Pharma Limited recommended a dividend of INR 1 per equity share of INR 10 each i.e. 10% on the paid up equity share capital of the Company, for the financial year ended March 31, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BLP:IN 71.50 INR +1.45

BLP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BLP.
View Industry Companies
 

Industry Analysis

BLP

Industry Average

Valuation BLP Industry Range
Price/Earnings 24.3x
Price/Sales 0.5x
Price/Book 1.6x
Price/Cash Flow 8.2x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BAL PHARMA LTD, please visit www.balpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.